Within3, a collaboration and communication service for the biotech and pharma industries, has raised over $100 million in new financing, the company said. The investment came from Insight Partners with participation from Silversmith Capital Partners. Most of the top 20 pharmaceutical companies already use the Lakewood, Ohio-based company’s service to publish clinical studies, host advisory boards, and collaborate with researchers and other participants in the drug development process, according to a statement from the company. Within3 said it would use the new funding to continue its product development and build additional capacity to support its growth. “Investment opportunities in companies like Within3 don’t come around very often,” said Deven Parekh, Managing Director at Insight Partners, in a statement.